ARCHIVES

Gleevec Approved For Pediatric CML

This article is from The Cancer Letter archive.

Vol. 29 No. 21 | May 23, 2003

Download PDF Visit The Full Archive

Related Articles

Central Line Safety Intervention Lowers Patient Infection Rate

October 25, 2013

Special Report on Cancer Centers: Three cancer centers win $9 million core grants, 11 of 13 competitors cut due to NCI budget shortfall.

January 16, 2004

Also In This 12-page Issue: NCI To Cut Budgets For New Grants By 29 Percent. R01s To Be Funded At 11th Percentile.

February 3, 2006

FDA Approves DNA Test For Two Types of HPV

March 27, 2009

NCI-Approved Clinical Trials

July 29, 2005

75% Of Fed Research Funds Pay Direct Costs, Study Says.

July 28, 2000